BIOMAT Database Logo BIOMAT Database Logo

Treatment of migraines and associated disorders with an alkaloid of hydrogen ergot. 1949

J P CHAPUIS

UI MeSH Term Description Entries
D008881 Migraine Disorders A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) Acute Confusional Migraine,Headache, Migraine,Status Migrainosus,Abdominal Migraine,Cervical Migraine Syndrome,Hemicrania Migraine,Migraine,Migraine Headache,Migraine Variant,Sick Headache,Abdominal Migraines,Acute Confusional Migraines,Cervical Migraine Syndromes,Disorder, Migraine,Disorders, Migraine,Headache, Sick,Headaches, Migraine,Headaches, Sick,Hemicrania Migraines,Migraine Disorder,Migraine Headaches,Migraine Syndrome, Cervical,Migraine Syndromes, Cervical,Migraine Variants,Migraine, Abdominal,Migraine, Acute Confusional,Migraine, Hemicrania,Migraines,Migraines, Abdominal,Migraines, Acute Confusional,Migraines, Hemicrania,Sick Headaches,Variant, Migraine,Variants, Migraine

Related Publications

J P CHAPUIS
Treatment of pseudopregnancy with bromocriptin, an ergot alkaloid.
August 1986, The Veterinary record,
J P CHAPUIS
Treatment of non-puerperal galactorrhoea with an ergot alkaloid.
July 1971, British medical journal,
J P CHAPUIS
ON AN ALKALOID FROM ERGOT.
July 1935, Science (New York, N.Y.),
J P CHAPUIS
Acute myocardial infarction associated with postpartum ergot alkaloid administration.
January 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
J P CHAPUIS
Ergot alkaloid fermentations.
January 1969, Advances in applied microbiology,
J P CHAPUIS
Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
July 1992, Annals of internal medicine,
J P CHAPUIS
Ergot alkaloid glycosides with immunomodulatory activities.
June 1996, Bioorganic & medicinal chemistry,
J P CHAPUIS
[Inhibition of prolactin by an ergot-alkaloid derivative].
January 1973, Gynakologische Rundschau,
J P CHAPUIS
[Effect of a hydrothermal treatment on ergot alkaloid content in ergot contaminated rye].
June 2005, Mycotoxin research,
J P CHAPUIS
THE NEW ERGOT ALKALOID.
August 1935, Science (New York, N.Y.),
Copied contents to your clipboard!